SpyBiotech is a UK-based biotechnology company that specializes in the development of vaccines and immunotherapies. The company's platform technology, SpyTag/SpyCatcher, enables the rapid production of vaccines and has applications in oncology, infectious diseases, and other therapeutic areas. SpyBiotech collaborates with academic institutions and pharmaceutical companies to advance vaccine research and development.

SpyBiotech

SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year. 

COM:SPYBIOTECH

SpyBiotech